SCHEMBL5380567

SCHEMBL5380567

O=Cc1ccc(OCCn2ncc3ccccc3c2=O)cc1

nearest known ligand 0.77

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.77
NPC1 O15118 5/20 0.77
PKM P14618 2/20 0.77
MITF O75030 1/20 0.77
KMT2A Q03164 1/20 0.63
MMP2 P08253 1/20 0.48
MMP3 P08254 1/20 0.48
MMP9 P14780 1/20 0.48
MMP13 P45452 1/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
KDM4E B2RXH2 2/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.42
NPBWR1 P48145 1/20 0.40
ALDH1A1 P00352 4/20 0.39
HTT P42858 1/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5377461 0.87 NPC1 (0.72) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7078524 0.85 NPC1 (0.69) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7078522 0.85 NPC1 (0.69) RAB9ANPC1PKMMITFKMT2A
SCHEMBL5384920 0.84 NPC1 (0.79) RAB9ANPC1PKMMITFKMT2A
SCHEMBL5454302 0.83 NPC1 (0.77) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7467062 0.82 NPC1 (0.64) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7457308 0.82 NPC1 (0.64) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7461773 0.78 PKM (0.54) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7461128 0.78 PKM (0.54) RAB9ANPC1PKMMITFKMT2A
SCHEMBL7074163 0.78 NPC1 (0.67) RAB9ANPC1PKMMITFKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179823-B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-20 US disclosed
EP-1457490-A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity Takeda Chemical Industries, Ltd. (JP) 2004-09-15 EP disclosed
EP-1228067-B1 5-MEMBERED N-HETEROCYCLIC COMPOUNDS WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2004-07-14 EP disclosed
EP-0903343-B1 Alpha-Substituted phenylpropionic acid derivative and medicine containing the same SSP CO LTD (JP) 2003-05-28 EP disclosed
EP-0971917-B1 THIAZOLIDINEDIONE AND OXAZOLIDINEDIONE DERIVATIVES HAVING ANTIDIABETIC, HYPOLIPIDAEMIC AND ANTIHYPERTENSIVE PROPERTIES REDDY RESEARCH FOUNDATION (IN) 2002-02-06 EP disclosed
EP-0971917-A1 THIAZOLIDINEDIONE AND OXAZOLIDINEDIONE DERIVATIVES HAVING ANTIDIABETIC, HYPOLIPIDAEMIC AND ANTIHYPERTENSIVE PROPERTIES DR. REDDY'S RESEARCH FOUNDATION (IN) 2000-01-19 EP disclosed
US-6011036-A Heterocyclic compounds having antidiabetic hypolipidemic antihypertensive properties process for their preparation and pharmaceutical compositions containing them DR. REDDY'S RESEARCH FOUNDATION (IN) 2000-01-04 US disclosed
EP-0903343-A1 Alpha-Substituted phenylpropionic acid derivative and medicine containing the same SSP Co., Ltd. (JP) 1999-03-24 EP disclosed
WO-1998045292-A1 THIAZOLIDINEDIONE AND OXAZOLIDINEDIONE DERIVATIVES HAVING ANTIDIABETIC, HYPOLIPIDAEMIC AND ANTIHYPERTENSIVE PROPERTIES DR. REDDY'S RESEARCH FOUNDATION (IN) 1998-10-15 WO disclosed